治疗的挑战 - 拉丁美洲专家共识的建议
Marco Rocha1, Franz Barnes2, Jemena Calderón3
1Universidade Federal de São Paulo, São Paulo, SP, Brazil; Sociedade Brasileira de Dermatologia, São Paulo, SP, Brazil.
Anais brasileiros de dermatologia
|February 24, 2024
概括
这项研究为皮肤科医生管理提供了最新的指导,涵盖了诸如Z世代和社交媒体影响等新挑战. 它为有效的治疗决策提供专家共识.
科学领域:
- 皮肤病学 皮肤病学
- 炎症性疾病 炎症性疾病
背景情况:
- 一般性是一种常见的pilosebaceous单位疾病,影响生活质量.
- 管理给医疗保健提供者带来了持续的挑战.
- 针对拉丁美洲的具体考虑得到了解决.
研究的目的:
- 为每日患者管理提供基于证据的建议.
- 为了应对当代治疗中的新出现的挑战.
- 在临床决策中支持皮肤科医生.
主要方法:
- 专家的共识是通过文献审查和Delphi方法论开发的.
- 八位具有广泛经验的专家参加了会议.
- 通过电子调查和网络研讨会,共识主题得到了精细化.
主要成果:
- 在关键管理声明上达成一致协议.
- 为具有挑战性的临床场景提供科学支持.
- 提供关于成人维护和Z世代特征的指导.
结论:
- 介绍了目前针对管理的基于证据的建议.
- 高级专家协议验证了治疗选择.
- 解决了包括社交媒体,Z世代和跨性别男性患者护理在内的新问题.
相关概念视频
Cystic Fibrosis: Management
164
Cystic fibrosis (CF) is an autosomal recessive disorder that predominantly affects individuals of Northern European descent, occurring at a rate of 1 in 3500. It is caused by a genetic mutation in a gene on chromosome 7, most commonly the ΔF508 mutation, that codes for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. This results in thicker mucus secretions and obstruction pathologies in multiple organs, including the lungs and sinuses.
Sinus disease and chronic...
Sinus disease and chronic...
164
Skin Cancer
4.1K
Skin cancer is a type of cancer that occurs when there is an abnormal growth of skin cells, usually triggered by damage to the DNA within the skin cells. It is primarily caused by exposure to ultraviolet (UV) radiation from the sun or artificial sources like tanning beds. Skin cancer is the most common type of cancer worldwide, and its incidence continues to rise.
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
4.1K
Chronic Pancreatitis II: Collaborative Care
90
The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:
Assessment:
90
Asthma-IV: Diagnostic and Management
2.5K
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
2.5K
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
297
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
297


